|     |   |
You are here: Investor Relations -> Investor Relations Home
Webcast ImageWebcast
Q2 2014 Mindray Medical International Limited Earnings Conference Call  (Live)
08/12/14 at 8:00 a.m. ET
Q2 2014 Mindray Medical International Limited Earnings Conference Call
Tuesday, August 12, 2014 8:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
In Focus
2014 First Quarter Financial Report
2013 Annual Report
2013 Fourth Quarter Financial Report
2013 Third Quarter Financial Report
Recent NewsMore >>
Mindray to Report Second Quarter 2014 Financial Results on August 11, 2014 - 07/15/14
SHENZHEN, China, July 15, 2014 /PRNewswire/ -- Mindray Medical International Limited ("Mindray", NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that it will report its financial results for the... More >>
Mindray Announces First Quarter 2014 Financial Results - 05/05/14
SHENZHEN, China, May 5, 2014 /PRNewswire/ -- Mindray Medical International Limited ("Mindray", NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the fi... More >>
Mindray Files Annual Report on Form 20-F with the U.S. Securities and Exchange Commission - 04/29/14
SHENZHEN, China, April 29, 2014 /PRNewswire/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer, and marketer of medical devices worldwide, announced today that it has filed with the Securities and Exchange Commiss... More >>
Mindray to Report First Quarter 2014 Financial Results on May 5, 2014 - 04/22/14
SHENZHEN, China, April 22, 2014 /PRNewswire/ -- Mindray Medical International Limited ("Mindray", NYSE: MR), a leading developer, manufacturer, and marketer of medical devices worldwide, today announced that it will report its financial results for t... More >>
Mindray Medical to Exhibit New Products at 71st China International Medical Equipment Fair - 04/03/14
SHENZHEN, China, April 3, 2014 /PRNewswire/ -- Mindray Medical International Limited ("Mindray", NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today that it will exhibit more than 70 innovative prod... More >>
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Mindray Medical International Limited posts new information to the site. Just enter your e-mail address and click Submit.
Stock Quote
Symbol MR (Common Stock)
ExchangeNYSE (US Dollar)
Price$30.41
Change (%) Stock is Up 0.60 (2.01%)
Volume189,446
Data as of 07/25/14 4:02 p.m. ET
Minimum 20 minute delay
Refresh quote
July 2014?
Calendar Help
This calendar contains six months of past and future company related information, which may include press releases, SEC filings, calendar events and more. Dates containing information are indicated by a colored background. You may hover your mouse over a date that contains an event to reveal the event or events taking place on that day including a link to additional information. This calendar requires JavaScript to be installed and activated on your browser.
Calendar Icon Legend:
Analyst Meeting
Conference
Conference Presentation
Corporate Conference Call
Custom Events
Earnings Conference Call
Earnings Release
Financial Reports
Other Corporate
Sales Release
Shareholders Meeting
News Release
SEC Filings
Presentations
52 Week High
Today
SunMonTueWedThuFriSat
-2-112345
6789101112
13141516171819
20212223242526
27282930315152
Upcoming EventsMore >>
DateTitleAdd to Calendar Help
08/12/14 8:00 a.m. ET
Q2 2014 Mindray Medical International Limited Earnings Conference Call
Add Q2 2014 Mindray Medical International Limited Earnings Conference Call   to Calendar

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.